Who
Jarrad Mattieu Aguirre
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Lyell Immunopharma.
In numbers
- Trades disclosed
- 3
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $3,642
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Sep 2026
- Last trade
- 12 Oct 2026
- Last filed
- 13 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Oct 2026filed 13 Oct 2026 | LYEL Lyell ImmunopharmaBiotechnology | SEC FORM 4 Sold | $3,642422 at $8.63 | filing |
| 10 Sep 2026filed 10 Sep 2026 | LYEL Lyell Immunopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,500 at $0.00 | filing |
| 10 Sep 2026filed 10 Sep 2026 | LYEL Lyell Immunopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,500 at $0.00 | filing |
News
Lyell Immunopharma (NASDAQ:LYEL) versus Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Critical ComparisonLYEL · themarketsdaily.com · 20 Oct 2026Reviewing Neuphoria Therapeutics (NASDAQ:NEUP) & Lyell Immunopharma (NASDAQ:LYEL)LYEL · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Jarrad Mattieu Aguirre; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.